
<!DOCTYPE html>
<html>
<meta charset="UTF-8">
<head>
  <title>Model Abstracts with Biological Entities (English) - 75 Topics / Sub-Topic Model 15 - 15 Topics</title>

<style>
table {
  font-family: "Trebuchet MS", Arial, Helvetica, sans-serif;
  border-collapse: collapse;
  width: 100%;
}

td, th {
  border: 1px solid #ddd;
  padding: 8px;
}

tr:nth-child(even){background-color: #f2f2f2;}

tr:hover {background-color: #ddd;}

th {
  padding-top: 12px;
  padding-bottom: 12px;
  text-align: left;
  background-color: #0099FF;
  color: white;
}
</style>

</head>
<body>
<h2>Model Abstracts with Biological Entities (English) - 75 Topics / Sub-Topic Model 15 - 15 Topics</h2>

        <ul>
        <li> <a href="pyldavis_text-ents-en-75-t15_15.html" target="_blank">Topic Visualization</a>
        <li> <a href="relevant_terms.html" target="_blank">Relevant Terms</a>
        <li> <a href="#trends">Topic Trends</a>
        </ul>
<h3>Summary</h3>
<ul>
        <li><em>Corpus Name:</em> Abstracts with Biological Entities (English) - 75 Topics / Sub-Topic Model 15
        <li><em>Number of Topics:</em> 15
        <li><em>Original Corpus Size:</em> 545
        <li><em>Total Unique Documents:</em> 520
        <li><em>Documents Repeated Across Topics:</em> 178
        <li><em>Documents Mentioning COVID-19 (or Coronavirus):</em> 60
        <li><em>Dataset:</em> 2020-04-24-v9
        <li><em>Corpus ID:</em> text-ents-en-75-t15
        </ul>
<h3>Overview</h3><p/>
<div><table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th></th>
      <th><a href="relevant_terms.html" target="_blank">Relevant Terms</a></th>
      <th>Documents</th>
      <th>Abstract Mentions COVID-19</th>
    </tr>
    <tr>
      <th>topic</th>
      <th></th>
      <th></th>
      <th></th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <th>t01</th>
      <td>drug(s), clinical, diseases, development, therapeutic, review, studies, current, trials</td>
      <td><a href="Topic_01.html" target="_blank">127</a></td>
      <td>10</td>
    </tr>
    <tr>
      <th>t02</th>
      <td>antiviral, viral, viruses, virus, host, replication, antiviral_drugs, development, viral_infections, infections</td>
      <td><a href="Topic_02.html" target="_blank">145</a></td>
      <td>7</td>
    </tr>
    <tr>
      <th>t03</th>
      <td>in_vitro, vitro, infection, vivo, effect, in_vivo, activity, cells, chloroquine, results</td>
      <td><a href="Topic_03.html" target="_blank">76</a></td>
      <td>16</td>
    </tr>
    <tr>
      <th>t04</th>
      <td>screening, discovery, drug, virtual, compounds, docking, lead, virtual_screening, silico, in_silico</td>
      <td><a href="Topic_04.html" target="_blank">40</a></td>
      <td>2</td>
    </tr>
    <tr>
      <th>t05</th>
      <td>coronavirus, sars-cov-2, COVID-19, sars-cov, SARS, syndrome, mers-cov, respiratory, coronaviruses, middle</td>
      <td><a href="Topic_05.html" target="_blank">52</a></td>
      <td>38</td>
    </tr>
    <tr>
      <th>t06</th>
      <td>peptide(s), antimicrobial, natural, amps, natural_products, products, bacteria, activities, antibiotics</td>
      <td><a href="Topic_06.html" target="_blank">44</a></td>
      <td>0</td>
    </tr>
    <tr>
      <th>t07</th>
      <td>delivery, rnai, sirna(s), interference, antisense, gene, nucleic, drug_delivery, RNA</td>
      <td><a href="Topic_07.html" target="_blank">36</a></td>
      <td>0</td>
    </tr>
    <tr>
      <th>t08</th>
      <td>influenza, M2, IAV, H5N1, H1N1, pandemic, neuraminidase, avian, oseltamivir, seasonal</td>
      <td><a href="Topic_08.html" target="_blank">26</a></td>
      <td>1</td>
    </tr>
    <tr>
      <th>t09</th>
      <td>inhibitor(s), norovirus, protease(s), molecule, enzyme, 3clpro, small_molecule, x-ray</td>
      <td><a href="Topic_09.html" target="_blank">22</a></td>
      <td>3</td>
    </tr>
    <tr>
      <th>t10</th>
      <td>ebola, EBOV, GS-5734, ebola_virus, EVD, fatality, niv, africa, favipiravir, fever</td>
      <td><a href="Topic_10.html" target="_blank">22</a></td>
      <td>1</td>
    </tr>
    <tr>
      <th>t11</th>
      <td>hepatitis, DNA, simplex, HCV, HRV, cytomegalovirus, HCMV, infections, herpes, HBV</td>
      <td><a href="Topic_11.html" target="_blank">24</a></td>
      <td>0</td>
    </tr>
    <tr>
      <th>t12</th>
      <td>agonists, diabetes, derivatives, ferroquine, antimalarial(s), malaria, effects, niclosamide, HCT</td>
      <td><a href="Topic_12.html" target="_blank">24</a></td>
      <td>0</td>
    </tr>
    <tr>
      <th>t13</th>
      <td>JEV, RSV, diarrhea, encephalitis, assay, VEEV, SCV, aureus, rotavirus, fda-approved</td>
      <td><a href="Topic_13.html" target="_blank">19</a></td>
      <td>1</td>
    </tr>
    <tr>
      <th>t14</th>
      <td>UPS, ubiquitin, IFN, oncolytic, proteasome, dubs, signaling, CEP, oncolytic_viruses, cancer</td>
      <td><a href="Topic_14.html" target="_blank">22</a></td>
      <td>0</td>
    </tr>
    <tr>
      <th>t15</th>
      <td>mab(s), monoclonal, antibodies, HCV, CQ, monoclonal_antibodies, HCQ, antibody, p7</td>
      <td><a href="Topic_15.html" target="_blank">19</a></td>
      <td>1</td>
    </tr>
  </tbody>
</table></div>

<h3 id="trends">Trends</h3>
<img src="topic_trends.png" border="1" width="1200px">

</body>
</html>
